Creative Medical Technology Holdings, Inc.
CELZ
$2.21
-$0.07-3.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | -- | -- | -- | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | -- | -- | -- | 0.00% |
| Cost of Revenue | -16.67% | -- | -- | -- | 0.00% |
| Gross Profit | 11.11% | -- | -- | -- | 0.00% |
| SG&A Expenses | -1.89% | 55.80% | 8.19% | 32.30% | -0.40% |
| Depreciation & Amortization | 36.73% | 6.14% | 4.78% | 4.44% | -11.37% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.18% | 14.72% | -22.64% | 48.12% | 6.42% |
| Operating Income | -3.19% | -14.72% | 22.26% | -47.85% | -6.43% |
| Income Before Tax | -1.81% | -18.83% | 20.83% | -57.28% | -10.46% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.81% | -18.83% | 20.83% | -57.28% | -10.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.81% | -18.83% | 20.83% | -57.28% | -10.46% |
| EBIT | -3.19% | -14.72% | 22.26% | -47.85% | -6.43% |
| EBITDA | -2.77% | -14.96% | 22.76% | -49.00% | -6.69% |
| EPS Basic | 35.42% | 35.90% | 56.89% | -12.87% | 10.39% |
| Normalized Basic EPS | 35.42% | 35.90% | 56.89% | -12.86% | 10.39% |
| EPS Diluted | 35.42% | 35.90% | 56.89% | -12.87% | 10.39% |
| Normalized Diluted EPS | 35.42% | 35.90% | 56.89% | -12.86% | 10.39% |
| Average Basic Shares Outstanding | 57.63% | 85.34% | 83.64% | 39.35% | 23.26% |
| Average Diluted Shares Outstanding | 57.63% | 85.34% | 83.64% | 39.35% | 23.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |